Disease-modifying therapies in multiple sclerosis – long-term outcomes and risk management

Understand why high-efficacy disease-modifying therapies have the potential for long-term disease control, and even improvement: mechanisms of action and individual benefit-risk profiles underpin logical and safe treatment plans